Corcept Therapeutics
CORT
#2171
Rank
โ‚ฌ5.97 B
Marketcap
56,63ย โ‚ฌ
Share price
2.83%
Change (1 day)
170.57%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2024 (TTM): โ‚ฌ0.62 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.59 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.43 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.64 B48.66%
2023 โ‚ฌ0.43 B16.48%
2022 โ‚ฌ0.37 B15.93%
2021 โ‚ฌ0.32 B12.32%
2020 โ‚ฌ0.28 B5.16%
2019 โ‚ฌ0.27 B24.57%
2018 โ‚ฌ0.21 B65.52%
2017 โ‚ฌ0.13 B71.62%
2016 โ‚ฌ77.31 M68.11%
2015 โ‚ฌ45.99 M110.66%
2014 โ‚ฌ21.83 M191.11%
2013 โ‚ฌ7.49 M199.98%
2012 โ‚ฌ2.5 M
2011 N/A
2010 N/A-100%
2009 โ‚ฌ0.02 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ77.77 B 13,057.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ42.29 B 7,055.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.28 B 7,562.06%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ39.43 B 6,572.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ55.71 B 9,325.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ56.18 B 9,405.81%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.29 B-50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.24 B-57.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.49 B 322.78%๐Ÿ‡บ๐Ÿ‡ธ USA